TORC1 and TORC2 converge to regulate the SAGA co-activator in response to nutrient availability

被引:31
|
作者
Laboucarie, Thomas [1 ]
Detilleux, Dylane [1 ]
Rodriguez-Mias, Ricard A. [2 ]
Faux, Celine [1 ]
Romeo, Yves [1 ,5 ]
Franz-Wachtel, Mirita [3 ]
Krug, Karsten [3 ]
Macek, Boris [3 ]
Villen, Judit [2 ]
Petersen, Janni [4 ]
Helmlinger, Dominique [1 ]
机构
[1] Univ Montpellier, CNRS, CRBM, Montpellier, France
[2] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA
[3] Proteome Ctr Tubingen, Tubingen, Germany
[4] Flinders Univ S Australia, Sch Med, Flinders Ctr Innovat Canc, Fac Hlth Sci, Adelaide, SA, Australia
[5] Univ Toulouse Paul Sabatier, CNRS, UMR 5099, Lab Biol Mol Eucaryote, Toulouse, France
关键词
differentiation; fission yeast; SAGA; signal transduction; TOR; transcription; PROTEIN PHOSPHATASE 2A; CELL-GROWTH CONTROL; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; SEXUAL-DIFFERENTIATION; TRANSCRIPTION FACTOR; SACCHAROMYCES-CEREVISIAE; BINDING PROTEIN; NITROGEN STARVATION; CONFORMATIONAL FLEXIBILITY;
D O I
10.15252/embr.201744942
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Gene expression regulation is essential for cells to adapt to changes in their environment. Co-activator complexes have well-established roles in transcriptional regulation, but less is known about how they sense and respond to signaling cues. We have previously shown that, in fission yeast, one such co-activator, the SAGA complex, controls gene expression and the switch from proliferation to differentiation in response to nutrient availability. Here, using a combination of genetic, biochemical, and proteomic approaches, we show that SAGA responds to nutrients through the differential phosphorylation of its Taf12 component, downstream of both the TORC1 and TORC2 pathways. Taf12 phosphorylation increases early upon starvation and is controlled by the opposing activities of the PP2A phosphatase, which is activated by TORC1, and the TORC2-activated Gad8(AKT) kinase. Mutational analyses suggest that Taf12 phosphorylation prevents cells from committing to differentiation until starvation reaches a critical level. Overall, our work reveals that SAGA is a direct target of nutrient-sensing pathways and has uncovered a mechanism by which TORC1 and TORC2 converge to control gene expression and cell fate decisions.
引用
收藏
页码:2197 / 2218
页数:22
相关论文
共 50 条
  • [31] Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models
    Gravina, Giovanni Luca
    Marampon, Francesco
    Sherris, David
    Vittorini, Francesca
    Di Cesare, Ernesto
    Tombolini, Vincenzo
    Lenzi, Andrea
    Jannini, Emmanuele A.
    Festuccia, Claudio
    PROSTATE, 2014, 74 (08): : 852 - 868
  • [32] Palomid 529, a Novel Small-Molecule Drug, Is a TORC1/TORC2 Inhibitor That Reduces Tumor Growth, Tumor Angiogenesis, and Vascular Permeability
    Xue, Qi
    Hopkins, Benjamin
    Perruzzi, Carole
    Udayakumar, Durga
    SherriS, David
    Benjamin, Laura E.
    CANCER RESEARCH, 2008, 68 (22) : 9551 - 9557
  • [33] The TORC1/TORC2 inhibitor, Palomid 529, reduces tumor growth and sensitizes to docetaxel and cisplatin in aggressive and hormone-refractory prostate cancer cells
    Gravina, Giovanni Luca
    Marampon, Francesco
    Petini, Foteini
    Biordi, Leda
    Sherris, David
    Jannini, Emmanuele A.
    Tombolini, Vincenzo
    Festuccia, Claudio
    ENDOCRINE-RELATED CANCER, 2011, 18 (04) : 385 - 400
  • [34] The reverse, but coordinated, roles of Tor2 (TORC1) and Tor1 (TORC2) kinases for growth, cell cycle and separase-mediated mitosis in Schizosaccharomyces pombe
    Ikai, Nobuyasu
    Nakazawa, Norihiko
    Hayashi, Takeshi
    Yanagida, Mitsuhiro
    OPEN BIOLOGY, 2011, 1
  • [35] TORC1 association with rDNA chromatin as a mechanism to co-regulate Pol I and Pol III
    Wei, Yuehua
    Zheng, X. F. Steven
    CELL CYCLE, 2009, 8 (23) : 3802 - 3803
  • [36] Intestinal Amino Acid Availability via PEPT-1 Affects TORC1/2 Signaling and the Unfolded Protein Response
    Geillinger, Kerstin E.
    Kuhlmann, Katja
    Eisenacher, Martin
    Giesbertz, Pieter
    Meyer, Helmut E.
    Daniel, Hannelore
    Spanier, Britta
    JOURNAL OF PROTEOME RESEARCH, 2014, 13 (08) : 3685 - 3692
  • [37] RES529, A DUAL TORC1/TORC2 INHIBITOR, POTENTIATES THE IN VITRO AND IN VIVO EFFICACY OF HORMONE MANIPULATIONS IN THE 22RV1 PROSTATE CANCER CELL MODEL
    Gravina, Giovanni Luca
    Marampon, Francesco
    Colapietro, Alessandro
    Scarsella, Luca
    Jitariuc, Ana
    Sanita, Patrizia
    Sherris, David
    Festuccia, Claudio
    ANTICANCER RESEARCH, 2015, 35 (06) : 3638 - 3639
  • [38] Potent Dual Inhibitors of TORC1 and TORC2 Complexes (KU-0063794 and KU-0068650) Demonstrate In Vitro and Ex Vivo Anti-Keloid Scar Activity
    Syed, Farhatullah
    Sanganee, Hitesh J.
    Bahl, Ashwani
    Bayat, Ardeshir
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 (05) : 1340 - 1350
  • [39] Phase I expansion trial of an oral TORC1/TORC2 inhibitor (CC-223) in diffuse large B-cell lymphoma (DLBCL) and multiple myeloma (MM)
    Goy, Andre
    Ribrag, Vincent
    Varga, Andrea
    Witzig, Thomas E.
    Ocio, Enrique M.
    Paz-Ares, Luis G.
    Mita, Monica M.
    Meyer, Tim
    Munster, Pamela N.
    Mahipal, Amit
    Delord, Jean-Pierre
    Arkenau, Hendrik-Tobias
    Gutierrez, Martin
    James, Angela
    Wong, Lilly
    Xu, Shuichan
    Wu, Xiaoling
    Carmichael, James
    Chopra, Rajesh
    Hege, Kristen
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [40] Roles for PI(3,5)P2 in nutrient sensing through TORC1
    Jin, Natsuko
    Mao, Kai
    Jin, Yui
    Tevzadze, Gela
    Kauffman, Emily J.
    Park, Sujin
    Bridges, Dave
    Loewith, Robbie
    Saltiel, Alan R.
    Klionsky, Daniel J.
    Weisman, Lois S.
    MOLECULAR BIOLOGY OF THE CELL, 2014, 25 (07) : 1171 - 1185